Triumph Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
Triumph Capital Management's RIGL Position: Q3 2026 in Review
Triumph Capital Management held its Rigel Pharmaceuticals (RIGL) position steady in Q3 2026 at 200 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.
Triumph Capital Management first reported a position in RIGL in Q4 2025 and has held it in 3 quarters since. 170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- Triumph Capital Management held 200 shares of Rigel Pharmaceuticals worth $9.6K as of Q3 2026.
- Triumph Capital Management left its Rigel Pharmaceuticals share count unchanged in Q3 2026.
- Rigel Pharmaceuticals made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1214 holding.
- Triumph Capital Management first reported a position in Rigel Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.